Cart
sales@molnova.com
Virstatin
CAS No. 88909-96-0
Virstatin( —— )
Catalog No. M28399 CAS No. 88909-96-0
Virstatin is a compound used as a molecular building block.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 10MG | 33 | In Stock |
|
| 25MG | 69 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 179 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVirstatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionVirstatin is a compound used as a molecular building block.
-
DescriptionVirstatin is a compound used as a molecular building block.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88909-96-0
-
Formula Weight283.283
-
Molecular FormulaC16H13NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (441.26 mM)
-
SMILESOC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Teneligliptin hydrob...
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.
-
Pro-xylane
Pro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
-
8-Hydroxyguanosine
8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.
